VR
Virpax Pharmaceuticals, Inc.
VRPX · OTC
$0.01 +0.00% (+$0.00)
1M +11,000.00%
Market Cap $124.0
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.01
9.9% downside
Current Price
$0.011
Undervalued Fair Value Overvalued
According to Bulios Fair Price, VRPX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
0/9Valuation
-
N/A P/FCF N/A
P/E N/A
P/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
57 /100
Average Asset turnover 0.00x
ROIC 1,322.00%
ROA 775.72%
Debt
6 /100
High Int. coverage -116.10x
Current ratio 0.63x
Debt/Assets N/A
Stability
1 /100
Unstable Profitable years 0
Beta 2.44x
EPS volatility 249.89%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about VRPX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jatinder Dhaliwal
Employees
2
Headquarters
Berwyn
Upcoming events
19 NOV
Earnings
Upcoming earnings report